Audio long read: The ‘breakthrough’ obesity drugs that have stunned researchers
Nature Podcast
00:00
Type 2 Diabetes and Weight Loss
Early clinical trial data showed that this treatment reduced body weight by up to around 15% after 12 weeks. Eli Lilly is conducting early stage clinical trials with drugs that target GIP alone, which Holst says will resolve the ongoing debate. Other gut hormones involved in appetite, such as peptide YY are being explored too.
Transcript
Play full episode
